Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

Maria G. Frank*, Gretchen Weaver, Vanessa Raabe, Richard T. Davey, Noreen A. Hynes, Mark G. Kortepeter, Nahid Bhadelia, Kerry Dierberg, Aneesh K. Mehta, Corri B. Levine, Peter C. Iwen, Denis A. Bente, Justin Chan, Adam Beitscher

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tickborne infection that can range from asymptomatic to fatal and has been described in >30 countries. Early identification and isolation of patients with suspected or confirmed CCHF and the use of appropriate prevention and control measures are essential for preventing human-to-human transmission. Here, we provide an overview of the epidemiology, clinical features, and prevention and control of CCHF. CCHF poses a continued public health threat given its wide geographic distribution, potential to spread to new regions, propensity for genetic variability, and potential for severe and fatal illness, in addition to the limited medical countermeasures for prophylaxis and treatment. A high index of suspicion, comprehensive travel and epidemiologic history, and clinical evaluation are essential for prompt diagnosis. Infection control measures can be effective in reducing the risk for transmission but require correct and consistent application.

Original languageEnglish
Pages (from-to)854-863
Number of pages10
JournalEmerging Infectious Diseases
Volume30
Issue number5
DOIs
StatePublished - May 2024

Fingerprint

Dive into the research topics of 'Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention'. Together they form a unique fingerprint.

Cite this